Sort
51,570 grants matching “autoimmune disease”
Cincinnati Rheumatic Diseases Resource Center
$797,315Leah Claire Kottyan · Cincinnati Childrens Hosp Med Ctr · P30 · FY2023 · AR
Immunotherapy of inflammation, autoimmune disease and cancer
$797,203Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
Mechanisms of gene expression
$797,097John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Defining the role of T cell help in germinal centers by intercellular enzymatic labeling
$797,082Gabriel D Victora · Rockefeller University · R01 · FY2023 · AI
Defining the role of T cell help in germinal centers by intercellular enzymatic labeling
$797,082Gabriel D Victora · Rockefeller University · R01 · FY2025 · AI
Defining the role of T cell help in germinal centers by intercellular enzymatic labeling
$797,082Gabriel D Victora · Rockefeller University · R01 · FY2024 · AI
Administrative Core
$797,077Judith A James · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2018 · GM
CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS
$796,925James J Chou · Harvard Medical School · R01 · FY2021 · AI
Mechanisms of Fibrosis in Asthma and Other Fibroproliferative Diseases
$796,846Thomas Wynn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis
$796,786Scott Scarneo · Eydis Bio, Inc. · R44 · FY2021 · AR
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS
$796,705University Of Texas Sw Med Ctr/Dallas · R01 · FY2000 · DK
Precision Phenomics to Personalize Drug Therapy (P3DT)
$796,664Joshua C. Denny · Vanderbilt University · P50 · FY2015 · GM
Assessment, Therapy and Prevention Of Autoimmune Disease
$796,504Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Mechanism of the transcription factor FoxP3 in regulatory T cell development
$796,500Sun Hur · Boston Children'S Hospital · R01 · FY2024 · AI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies
$796,377Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Development and Clinical Application of Gene and Cell therapies for Patients with Immune Deficiencies
$796,377Suk See De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
eQTL mega-analysis for functional assessment of multi-enhancer gene regulation
$796,375Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2016 · HG
VISTA is a negative checkpoint regulator of innate immunity
$796,349Randolph J. Noelle · Dartmouth College · R01 · FY2023 · AI
Pathobiology of autoimmune-mediated diffuse podocytopathy
$796,293Astrid Weins · Brigham And Women'S Hospital · R01 · FY2024 · DK
TNF-receptors and programmed cell death in regulation of autoimmunity
$796,027Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2018 · AR
Determining role of 14-3-3zeta in IL-17A signaling
$795,696Ritu Chakravarti · University Of Kentucky · R01 · FY2025 · AI
Adoptive Cellular Therapies to Enhance Tolerance and Protective Immunity
$795,622Leslie S Kean · Emory University · U19 · FY2008 · AI
Mesenchymal stem cell enhancement of organ allograft repair and long term surviva
$795,606Amelia M. Bartholomew · University Of Miami School Of Medicine · P01 · FY2011 · AI
Monoclonal Antibodies for Alzheimer's Immunotherapy
$795,545Andrew C Hiatt · Mapp Biopharmaceutical, Inc. · R44 · FY2008 · AG
DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME
$795,484Laura Santambrogio · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI